MetaCap

Celcuity (CELC) News

NASDAQ: CELCHealth CareMedical SpecialitiesUSD

53.35-2.96 (-5.26%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CELC news summary

We found 12 recent headlines mentioning Celcuity (CELC): 0 in the past week and 8 in the past 30 days, most often from GlobeNewswire, Nasdaq, Seeking Alpha. CELC is making an outsized move today, down 5.26% at $53.35, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Celcuity Announces FDA Acceptance of sNDA for REVTORPYK™ (gedatolisib) for HR+/HER2-, PIK3CA Mutant Locally Advanced or Metastatic Breast Cancer", was published by GlobeNewswire on Nov 9, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Celcuity headlines

Stocks mentioned alongside CELC

Compare CELC